{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:41:03Z","timestamp":1780983663996,"version":"3.54.1"},"publisher-location":"Cham","reference-count":56,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319524429","type":"print"},{"value":"9783319524443","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/7854_2016_41","type":"book-chapter","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T11:42:27Z","timestamp":1478691747000},"page":"19-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Structure-Activity Relationships of Synthetic Cathinones"],"prefix":"10.1007","author":[{"given":"Richard A.","family":"Glennon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Dukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"key":"41_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/9781118023150","volume-title":"Drug discrimination: applications to medicinal chemistry and drug studies","author":"RA Glennon","year":"2011","unstructured":"Glennon RA, Young R (2011) Drug discrimination: applications to medicinal chemistry and drug studies. Wiley, Hoboken"},{"key":"41_CR2","volume-title":"The challenge of new psychoactive substances","author":"UNODC","year":"2013","unstructured":"UNODC (2013) The challenge of new psychoactive substances. United Nations Office of Drugs and Crime, Vienna"},{"key":"41_CR3","unstructured":"EMCDDA (2015) European Drug Report. Trends and Developments. European Monitoring Centre for Drugs and Drug Addiction. Luxembourg"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","volume":"69","author":"RA Glennon","year":"2014","unstructured":"Glennon RA (2014) Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol 69:581\u2013620","journal-title":"Adv Pharmacol"},{"key":"41_CR5","first-page":"186","volume":"2","author":"RA Glennon","year":"1981","unstructured":"Glennon RA, Showalter D (1981) The effect of cathinone and several related derivatives on locomotor activity. Res Commun Subst Abus 2:186\u2013192","journal-title":"Res Commun Subst Abus"},{"key":"41_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(84)90121-7","volume":"21","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Schechter MD, Rosecrans JA (1984) Discriminative stimulus properties of S(\u2212)- and R(+)-cathinone, (+)-cathine and several structural modifications. Pharmacol Biochem Behav 21:1\u20133","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0091-3057(84)80071-4","volume":"21","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Young R, Hauck AE, et al. (1984) Structure-activity studies on amphetamine analogs using drug discrimination methodology. Pharmacol Biochem Behav 21:895\u2013901","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0028-3908(86)90063-8","volume":"25","author":"AJ Goudie","year":"1986","unstructured":"Goudie AJ, Atkinson J, West CR (1986) Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation. Neuropharmacology 25:85\u201394","journal-title":"Neuropharmacology"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/0006-2952(86)90380-1","volume":"35","author":"P Kalix","year":"1986","unstructured":"Kalix P, Glennon RA (1986) Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. Biochem Pharmacol 35:3015\u20133019","journal-title":"Biochem Pharmacol"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","volume":"147","author":"MEA Reith","year":"2015","unstructured":"Reith MEA, Blough BE, Hong WC, et al. (2015) Behavioral, biological, and chemical perspectives on a typical agents targeting the dopamine transporter. Drug Alcohol Depend 147:1\u201319","journal-title":"Drug Alcohol Depend"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/cn500282f","volume":"6","author":"QY Tang","year":"2015","unstructured":"Tang QY, Kolanos R, De Felice LJ, et al. (2015) Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter. ACS Chem Neurosci 6:551\u2013558","journal-title":"ACS Chem Neurosci"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0091-3057(97)00323-7","volume":"58","author":"TA Dal Cason","year":"1997","unstructured":"Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58:1109\u20131116","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0091-3057(87)90164-X","volume":"26","author":"RA Glennon","year":"1987","unstructured":"Glennon RA, Yousif M, Naiman N, et al. (1987) Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 26:547\u2013551","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0091-3057(02)00963-2","volume":"74","author":"TS Bondareva","year":"2002","unstructured":"Bondareva TS, Young R, Glennon RA (2002) Central stimulants as discriminative stimuli: asymmetric generalization between (\u2212)ephedrine and S(+)methamphetamine. Pharmacol Biochem Behav 74:157\u2013162","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-3057(98)00055-0","volume":"60","author":"R Young","year":"1998","unstructured":"Young R, Glennon RA (1998) Discriminative stimulus properties of (\u2212)ephedrine. Pharmacol Biochem Behav 60:771\u2013775","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ddr.10297","volume":"60","author":"KF Foley","year":"2003","unstructured":"Foley KF, Cozzi NV (2003) Novel aminopropiophenones as potential antidepressants. Drug Dev Res 60:252\u2013260","journal-title":"Drug Dev Res"},{"key":"41_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(03)02010-7","volume":"474","author":"ML Bondarev","year":"2003","unstructured":"Bondarev ML, Bondareva TS, Young R, et al. (2003) Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol 474:85\u201393","journal-title":"Eur J Pharmacol"},{"key":"41_CR18","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1021\/jm901189z","volume":"52","author":"FI Carroll","year":"2009","unstructured":"Carroll FI, Blough BE, Abraham P, et al. (2009) Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J Med Chem 52:6768\u20136781","journal-title":"J Med Chem"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0006-2952(86)90230-3","volume":"35","author":"SL Markantonis","year":"1986","unstructured":"Markantonis SL, Kyroudis A, Beckett AH (1986) The stereoselective metabolism of dimethylpropion and monomethylpropion. Biochem Pharmacol 35:529\u2013532","journal-title":"Biochem Pharmacol"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2012.11.008","volume":"699","author":"NV Cozzi","year":"2013","unstructured":"Cozzi NV, Brandt SD, Daley PF, et al. (2013) Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. Eur J Pharmacol 699:180\u2013187","journal-title":"Eur J Pharmacol"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0091-3057(93)90110-F","volume":"45","author":"R Young","year":"1993","unstructured":"Young R, Glennon RA (1993) Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex. Pharmacol Biochem Behav 45:229\u2013231","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR22","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1017\/S146114571300059X","volume":"16","author":"SJ Kohut","year":"2013","unstructured":"Kohut SJ, Fivel PA, Blough BE, et al. (2013) Effects of methcathinone and 3-Cl-methcathinone (PAL-434) in cocaine discrimination or self-administration in rhesus monkeys. Int J Neuropsychopharmacol 16:1985\u20131998","journal-title":"Int J Neuropsychopharmacol"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s002130050765","volume":"140","author":"R Young","year":"1998","unstructured":"Young R, Glennon RA (1998) Discriminative stimulus effects of S(\u2212)-methcathinone (CAT): a potent stimulant drug of abuse. Psychopharmacology (Berl) 140:250\u2013256","journal-title":"Psychopharmacology (Berl)"},{"key":"41_CR24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","volume":"307","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Vu N, Partilla JS, et al. (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective action as norepinephrine transporter substrates. J Pharmacol Exp Ther 307:138\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0091-3057(00)00173-8","volume":"66","author":"R Young","year":"2000","unstructured":"Young R, Glennon RA (2000) Stimulus effects of phenylpropanolamine optical isomers in (+)amphetamine-trained rats. Pharmacol Biochem Behav 66:489\u2013494","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR26","unstructured":"Iversen LE (2010) Consideration of the cathinones. Advisory Council on the Misuse of Drugs. A report submitted to the Home Secretary of the UK (March 31, 2010)"},{"key":"41_CR27","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/jm050797a","volume":"49","author":"PC Meltzer","year":"2006","unstructured":"Meltzer PC, Butler D, Deschamps JR, et al. (2006) 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49:1420\u20131432","journal-title":"J Med Chem"},{"key":"41_CR28","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","volume":"232","author":"SM Aarde","year":"2015","unstructured":"Aarde SM, Creehan KM, Vandewater SA, et al. (2015) In vivo potency and efficacy of the novel cathinone \u03b1-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology (Berl) 232:3045\u20133055","journal-title":"Psychopharmacology (Berl)"},{"key":"41_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","volume":"71","author":"SM Aarde","year":"2013","unstructured":"Aarde SM, Huang PK, Creehan KM, et al. (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130\u2013140","journal-title":"Neuropharmacology"},{"key":"41_CR30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, et al. (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38:552\u2013562","journal-title":"Neuropsychopharmacology"},{"key":"41_CR31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","volume":"38","author":"WE Fantegrossi","year":"2013","unstructured":"Fantegrossi WE, Gannon BM, Zimmerman SM, et al. (2013) In vivo effects of abused \u2018bath salt\u2019 constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38:563\u2013573","journal-title":"Neuropsychopharmacology"},{"key":"41_CR32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.115.223586","volume":"354","author":"MB Gatch","year":"2015","unstructured":"Gatch MB, Dolan SB, Forster MJ (2015) Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives. J Pharmacol Exp Ther 354:103\u2013110","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL, et al. (2014) Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213","journal-title":"Neuropharmacology"},{"key":"41_CR34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.neuro.2012.08.003","volume":"33","author":"JA Marusich","year":"2012","unstructured":"Marusich JA, Grant KR, Blough BE, et al. (2012) Effects of synthetic cathinones contained in \u201cbath salts\u201d on motor behavior and a functional observational battery in mice. Neurotoxicology 33:1305\u20131313","journal-title":"Neurotoxicology"},{"key":"41_CR35","doi-asserted-by":"crossref","first-page":"209875","DOI":"10.1155\/2014\/209875","volume":"2014","author":"LR Watterson","year":"2014","unstructured":"Watterson LR, Olive MF (2014) Synthetic cathinones and their rewarding and reinforcing effects in rodents. Adv Neurosci 2014:209875","journal-title":"Adv Neurosci"},{"key":"41_CR36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"LR Watterson","year":"2014","unstructured":"Watterson LR, Kufahl PR, Nemirovsky NE, et al. (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19:165\u2013174","journal-title":"Addict Biol"},{"key":"41_CR37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","volume":"24","author":"MB Gatch","year":"2013","unstructured":"Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of \u2018bath salt\u2019 cathinones. Behav Pharmacol 24:437\u2013447","journal-title":"Behav Pharmacol"},{"key":"41_CR38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/bph.12061","volume":"168","author":"K Cameron","year":"2013","unstructured":"Cameron K, Kolanos R, Solis E, et al. (2013) Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 168:1750\u20131757","journal-title":"Br J Pharmacol"},{"key":"41_CR39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-013-2967-2","volume":"227","author":"K Cameron","year":"2013","unstructured":"Cameron K, Kolanos R, Vekariya R, et al. (2013) Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of \u201cbath salts,\u201d produce opposite effects at the human dopamine transporter. Psychopharmacology (Berl) 227:493\u2013499","journal-title":"Psychopharmacology (Berl)"},{"key":"41_CR40","unstructured":"Kolanos R, Cameron KN, Vekariya RH et al (2011) \u201cBath salts\u201d: an imitation of methamphetamine plus cocaine? Abstract #249. Southeast Regional American Chemical Society Meeting. Richmond, VA"},{"key":"41_CR41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, et al. (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470","journal-title":"Br J Pharmacol"},{"key":"41_CR42","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, et al. (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803\u20131815","journal-title":"Biochem Pharmacol"},{"key":"41_CR43","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.bmc.2015.07.035","volume":"23","author":"F Del Bello","year":"2015","unstructured":"Del Bello F, Sakloth F, Partilla JS, et al. (2015) Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: interactions with transporters for serotonin, dopamine, and norepinephrine. Bioorg Med Chem 23:5574\u20135579","journal-title":"Bioorg Med Chem"},{"key":"41_CR44","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/cn4001236","volume":"4","author":"R Kolanos","year":"2013","unstructured":"Kolanos R, Solis Jr E, Sakloth F, et al. (2013) \u201cdeconstruction\u201d of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. ACS Chem Neurosci 4:1524\u20131529","journal-title":"ACS Chem Neurosci"},{"key":"41_CR45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/acschemneuro.5b00006","volume":"20","author":"R Kolanos","year":"2015","unstructured":"Kolanos R, Partilla JS, Baumann MH, et al. (2015) Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats. ACS Chem Neurosci 20:771\u2013777","journal-title":"ACS Chem Neurosci"},{"key":"41_CR46","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/bph.13043","volume":"172","author":"F Sakloth","year":"2015","unstructured":"Sakloth F, Kolanos R, Mosier PD, et al. (2015) Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2210\u20132218","journal-title":"Br J Pharmacol"},{"key":"41_CR47","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acschemneuro.5b00160","volume":"6","author":"R Kolanos","year":"2015","unstructured":"Kolanos R, Sakloth F, Jain AD, et al. (2015) Structural modification of the designer stimulant \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) influences potency at dopamine transporters. ACS Chem Neurosci 6:1726\u20131731","journal-title":"ACS Chem Neurosci"},{"key":"41_CR48","unstructured":"Sakloth F (2015) Psychoactive synthetic cathinones (or \u2018bath salts\u2019): investigation of mechanisms of action. PhD dissertation, Virginia Commonwealth University, Richmond, VA"},{"key":"41_CR49","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bph.13030","volume":"172","author":"JS Bonano","year":"2015","unstructured":"Bonano JS, Banks ML, Kolanos R, et al. (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2433\u20132444","journal-title":"Br J Pharmacol"},{"key":"41_CR50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bph.12951","volume":"172","author":"RA Gregg","year":"2015","unstructured":"Gregg RA, Baumann MH, Partilla JS, et al. (2015) Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. Br J Pharmacol 172:883\u2013894","journal-title":"Br J Pharmacol"},{"key":"41_CR51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.euroneuro.2015.12.010","volume":"26","author":"BA Hutsell","year":"2016","unstructured":"Hutsell BA, Baumann MH, Partilla JS, et al. (2016) Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats. Eur Neuropsychopharmacol 26:288\u2013297","journal-title":"Eur Neuropsychopharmacol"},{"key":"41_CR52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.115.229559","volume":"356","author":"JA Suyama","year":"2016","unstructured":"Suyama JA, Sakloth F, Kolanos R, et al. (2016) Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: microdialysis studies of nucleus accumbens dopamine and serotonin. J Pharmacol Exp Ther 356:182\u2013190","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR53","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.106.107383","volume":"320","author":"SS Negus","year":"2007","unstructured":"Negus SS, Mello NK, Blough BE, et al. (2007) Monoamine releasers with varying selectivity for dopamine\/norepinephrine versus serotonin release as candidate \u201cagonist\u201d medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:627\u2013636","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR54","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/npp.2014.325","volume":"40","author":"K Saha","year":"2015","unstructured":"Saha K, Partilla JS, Lehner KR, et al. (2015) \u2018Second-generation\u2019 mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40:1321\u20131331","journal-title":"Neuropsychopharmacology"},{"key":"41_CR55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11419-015-0295-4","volume":"34","author":"M Majchrzak","year":"2016","unstructured":"Majchrzak M, Rojkiewicz M, Celi\u0144ski R, et al. (2016) Identification and characterization of new designer drug 4-fluoro-PV9 and \u03b1-PHP in the seized materials. Forensic Toxicol 34:115\u2013124","journal-title":"Forensic Toxicol"},{"key":"41_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.013","volume":"243","author":"N Uchiyama","year":"2014","unstructured":"Uchiyama N, Matsuda S, Kawamura M, et al. (2014) Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, \u03b1-PHPP and \u03b1-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci Int 243:1\u201313","journal-title":"Forensic Sci Int"}],"container-title":["Current Topics in Behavioral Neurosciences","Neuropharmacology of New Psychoactive Substances (NPS)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2016_41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T06:19:59Z","timestamp":1700201999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2016_41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319524429","9783319524443"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/7854_2016_41","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"10 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}